Cargando…
Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease
BACKGROUND: Western drugs have achieved great successes in CVDs treatment. However, they may lead to some side effects and drug resistance. On the other hand, more and more studies found that Traditional Chinese herbs have efficient therapeutic effects for CVDs, while their therapeutic mechanism is...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095000/ https://www.ncbi.nlm.nih.gov/pubmed/25104437 http://dx.doi.org/10.1186/1471-2105-15-S4-S3 |
_version_ | 1782325935938207744 |
---|---|
author | Fu, Peng Yang, Linlin Sun, Yi Ye, Li Cao, Zhiwei Tang, Kailin |
author_facet | Fu, Peng Yang, Linlin Sun, Yi Ye, Li Cao, Zhiwei Tang, Kailin |
author_sort | Fu, Peng |
collection | PubMed |
description | BACKGROUND: Western drugs have achieved great successes in CVDs treatment. However, they may lead to some side effects and drug resistance. On the other hand, more and more studies found that Traditional Chinese herbs have efficient therapeutic effects for CVDs, while their therapeutic mechanism is still not very clear. It may be a good view towards molecules, targets and network to decipher whether difference exists between anti-CVD western drugs and Chinese herbal ingredients. RESULTS: Anti-CVD western drugs and Chinese herbal ingredients, as well as their targets were thoroughly collected in this work. The similarities and the differences between the herbal ingredients and the western drugs were deeply explored based on three target-based perspectives including biochemical property, regulated pathway and disease network. The biological function of herbal ingredients' targets is more complex than that of the western drugs' targets. The signal transduction and immune system associated signaling pathways, apoptosis associated pathways may be the most important pathway for herbal ingredients, however the western drugs incline to regulate vascular smooth muscle contraction associated pathways. Chinese herbal ingredients prefer to regulate the downstream proteins of apoptosis associated pathway; while the western drugs incline to regulate the upstream proteins of VECC (Vascular Epidermal Cells Contraction) related pathways. CONCLUSION: In summary, the characteristics identified in this study would be valuable for designing new network-based multi-target CVD drugs or vaccine adjuvants. |
format | Online Article Text |
id | pubmed-4095000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40950002014-07-23 Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease Fu, Peng Yang, Linlin Sun, Yi Ye, Li Cao, Zhiwei Tang, Kailin BMC Bioinformatics Research BACKGROUND: Western drugs have achieved great successes in CVDs treatment. However, they may lead to some side effects and drug resistance. On the other hand, more and more studies found that Traditional Chinese herbs have efficient therapeutic effects for CVDs, while their therapeutic mechanism is still not very clear. It may be a good view towards molecules, targets and network to decipher whether difference exists between anti-CVD western drugs and Chinese herbal ingredients. RESULTS: Anti-CVD western drugs and Chinese herbal ingredients, as well as their targets were thoroughly collected in this work. The similarities and the differences between the herbal ingredients and the western drugs were deeply explored based on three target-based perspectives including biochemical property, regulated pathway and disease network. The biological function of herbal ingredients' targets is more complex than that of the western drugs' targets. The signal transduction and immune system associated signaling pathways, apoptosis associated pathways may be the most important pathway for herbal ingredients, however the western drugs incline to regulate vascular smooth muscle contraction associated pathways. Chinese herbal ingredients prefer to regulate the downstream proteins of apoptosis associated pathway; while the western drugs incline to regulate the upstream proteins of VECC (Vascular Epidermal Cells Contraction) related pathways. CONCLUSION: In summary, the characteristics identified in this study would be valuable for designing new network-based multi-target CVD drugs or vaccine adjuvants. BioMed Central 2014-03-19 /pmc/articles/PMC4095000/ /pubmed/25104437 http://dx.doi.org/10.1186/1471-2105-15-S4-S3 Text en Copyright © 2014 Fu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Fu, Peng Yang, Linlin Sun, Yi Ye, Li Cao, Zhiwei Tang, Kailin Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
title | Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
title_full | Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
title_fullStr | Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
title_full_unstemmed | Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
title_short | Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease |
title_sort | target network differences between western drugs and chinese herbal ingredients in treating cardiovascular disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095000/ https://www.ncbi.nlm.nih.gov/pubmed/25104437 http://dx.doi.org/10.1186/1471-2105-15-S4-S3 |
work_keys_str_mv | AT fupeng targetnetworkdifferencesbetweenwesterndrugsandchineseherbalingredientsintreatingcardiovasculardisease AT yanglinlin targetnetworkdifferencesbetweenwesterndrugsandchineseherbalingredientsintreatingcardiovasculardisease AT sunyi targetnetworkdifferencesbetweenwesterndrugsandchineseherbalingredientsintreatingcardiovasculardisease AT yeli targetnetworkdifferencesbetweenwesterndrugsandchineseherbalingredientsintreatingcardiovasculardisease AT caozhiwei targetnetworkdifferencesbetweenwesterndrugsandchineseherbalingredientsintreatingcardiovasculardisease AT tangkailin targetnetworkdifferencesbetweenwesterndrugsandchineseherbalingredientsintreatingcardiovasculardisease |